Tech Company Financing Transactions
Unlearn.AI Funding Round
Altimeter Capital, EPIC Ventures and Mubadala joined a $50 million Series C venture round for Unlearn.AI. The round was recorded on 2/8/2024.
Transaction Overview
Company Name
Announced On
2/8/2024
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series C
Investors
Proceeds Purpose
The company intends to use the funds to advance AI to eliminate trial and error in medicine by investing in its people, data, engineering capabilities, and longer-term R&D initiatives.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
450 Geary St. 200
San Francisco, CA 94102
USA
San Francisco, CA 94102
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Unlearn has developed the first machine learning (ML) platform for creating Intelligent Control Arms with Digital Twins through its proprietary DiGenesis?? process, allowing drug developers to dramatically improve clinical evidence and trial power, while lowering the risk of trial failure, thereby increasing confidence in clinical trial results.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles Fisher
Chief Operating Officer
Graham Siegel
Founder
Aaron Smith
Founder
Jon Walsh
VP - Bus. Development
Julia Coelho
Browse more venture capital transactions:
Prev: 2/8/2024: Nicer venture capital transaction
Next: 2/8/2024: Perigon venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs